Interpace Diagnostics Group, Inc. (NasdaqCM:IDXG) will seek acquisition. Interspace has filed a Follow-on Equity Offering and intends to use the net proceeds of the offering for working capital, capital expenditures, business development and research and development expenditures, and acquisition of new technologies and businesses.